The glucagon-like peptides: a double-edged therapeutic sword?

Trends Pharmacol Sci. 2003 Jul;24(7):377-83. doi: 10.1016/S0165-6147(03)00160-3.
No abstract available

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism
  • Exenatide
  • Glucagon / chemistry
  • Glucagon / pharmacology*
  • Glucagon / physiology
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Insulin / metabolism
  • Insulin Secretion
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology*
  • Peptide Fragments / physiology
  • Peptides / chemistry
  • Peptides / pharmacology
  • Protein Precursors / chemistry
  • Protein Precursors / pharmacology*
  • Protein Precursors / physiology
  • Receptors, Glucagon / agonists*
  • Receptors, Glucagon / biosynthesis
  • Venoms*

Substances

  • GLP1R protein, human
  • Glucagon-Like Peptide-1 Receptor
  • Insulin
  • Peptide Fragments
  • Peptides
  • Protein Precursors
  • Receptors, Glucagon
  • Venoms
  • Glucagon-Like Peptide 1
  • Glucagon
  • Exenatide